Kempner Capital Management Has Lowered Its Mosaic Co. (The) (MOS) Holding; Iridex (IRIX) Has …

Kempner Capital Management Inc sold 48,458 shares as Mosaic Co. … Quantum Capital Management, a California-based fund reported 28,829 …

The Mosaic Company (NYSE:MOS) Logo

Kempner Capital Management Inc decreased Mosaic Co. (The) (MOS) stake by 44.05% reported in 2018Q4 SEC filing. Kempner Capital Management Inc sold 48,458 shares as Mosaic Co. (The) (MOS)’s stock declined 12.74%. The Kempner Capital Management Inc holds 61,557 shares with $1.80 million value, down from 110,015 last quarter. Mosaic Co. (The) now has $8.97 billion valuation. The stock decreased 7.99% or $2.02 during the last trading session, reaching $23.25. About 11.04M shares traded or 147.53% up from the average. The Mosaic Company (NYSE:MOS) has risen 16.92% since May 8, 2018 and is uptrending. It has outperformed by 12.55% the S&P500. Some Historical MOS News: 10/05/2018 – MOSAIC CO MOS.N : RBC RAISES TO OUTPERFORM FROM SECTOR PERFORM; 10/05/2018 – The Mosaic Company Announces Board of Director Changes; 07/05/2018 – MOSAIC CO SEES 2018 ADJUSTED EARNINGS PER SHARE $1.20 – $1.60 PER SHARE; 06/03/2018 Consolidated Research: 2018 Summary Expectations for SandRidge Energy, BIOVERATIV INC, Ultra Clean, The Mosaic, Papa John’s Int; 08/05/2018 – MOSAIC: RESTRUCTURING PACE IN CHINA PHOSPHATE TO CONTINUE; 08/05/2018 – MOSAIC EXPECTS PRICES WILL STAY FIRM LATER IN 2018; 10/05/2018 – MOSAIC CO MOS.N : RBC RAISES TARGET PRICE TO $32 FROM $30; 07/05/2018 – MOSAIC CO SEES FY 2018 CAPITAL EXPENDITURES $900 MLN – $1,100 MLN; 21/03/2018 – FITCH AFFIRMS MOSAIC’S IDR AT ‘BBB-‘; OUTLOOK STABLE; 08/05/2018 – MOSAIC CO MOS.N : UBS RAISES TARGET PRICE TO $34 FROM $33

Iridex Corp (IRIX) investors sentiment decreased to 0.71 in Q4 2018. It’s down -1.07, from 1.78 in 2018Q3. The ratio has dropped, as 10 institutional investors increased and started new holdings, while 14 decreased and sold their positions in Iridex Corp. The institutional investors in our database now own: 5.97 million shares, down from 7.05 million shares in 2018Q3. Also, the number of institutional investors holding Iridex Corp in top ten holdings was flat from 2 to 2 for the same number . Sold All: 3 Reduced: 11 Increased: 7 New Position: 3.

Paragon Associates & Paragon Associates Ii Joint Venture holds 8.24% of its portfolio in IRIDEX Corporation for 1.32 million shares. Acuta Capital Partners Llc owns 1.17 million shares or 4.21% of their US portfolio. Moreover, Perkins Capital Management Inc has 0.39% invested in the company for 107,250 shares. The Utah-based Wasatch Advisors Inc has invested 0.09% in the stock. Quantum Capital Management, a California-based fund reported 28,829 shares.

IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company has market cap of $68.85 million. The firm offers laser consoles, such as Cyclo G6 laser system used for the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It currently has negative earnings. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physicians to perform multi-spot pattern scanning; Slit Lamp Adapter, which allows the physicians to utilize a standard slit lamp in diagnosis and treatment procedures; and TruFocus laser indirect ophthalmoscopes for use in procedures to treat peripheral retinal disorders.

Since January 1, 0001, it had 5 insider buys, and 0 sales for $186,054 activity.

The stock decreased 0.98% or $0.05 during the last trading session, reaching $5.05. About 7,522 shares traded. IRIDEX Corporation (IRIX) has declined 18.71% since May 8, 2018 and is downtrending. It has underperformed by 23.08% the S&P500. Some Historical IRIX News: 08/03/2018 – Iridex 4Q Rev $10.2M; 03/05/2018 – Iridex 1Q Loss/Shr 31c; 19/04/2018 – DJ IRIDEX Corporation, Inst Holders, 1Q 2018 (IRIX); 03/05/2018 – IRIDEX CORP QTRLY SHR LOSS $0.31; 03/05/2018 – Iridex Sees 2018 Rev $37M-$41M; 20/03/2018 – lridex Receives CE Mark for Transilluminated Probe; 16/04/2018 – IRIDEX Announces Appointment of Maria Sainz and David Bruce to its Board of Directors; 08/03/2018 – IRIDEX CORP IRIX.O SEES FY 2018 REVENUE $37 MLN TO $41 MLN; 20/03/2018 – IRIDEX GETS CE MARK FOR TRANSILLUMINATED PROBE; 16/04/2018 – IRIDEX Announces Appointment of Maria Sainz and David Bruce to Its Bd of Directors

Analysts await IRIDEX Corporation (NASDAQ:IRIX) to report earnings on August, 1. They expect $-0.21 earnings per share, up 25.00% or $0.07 from last year’s $-0.28 per share. After $-0.22 actual earnings per share reported by IRIDEX Corporation for the previous quarter, Wall Street now forecasts -4.55% EPS growth.

More notable recent IRIDEX Corporation (NASDAQ:IRIX) news were published by: Globenewswire.com which released: “Scott Shuda Appointed to IRIDEX Board of Directors – GlobeNewswire” on April 29, 2019, also Nasdaq.com with their article: “Iridex (IRIX) Reports Q1 Loss, Tops Revenue Estimates – Nasdaq” published on May 02, 2019, Nasdaq.com published: “Iridex (IRIX) May Report Negative Earnings: Know the Trend Ahead of Next Week’s Release – Nasdaq” on April 25, 2019. More interesting news about IRIDEX Corporation (NASDAQ:IRIX) were released by: Nasdaq.com and their article: “IRIDEX’s MicroPulse® Laser Technology Featured in Several Glaucoma and Retina Research Presentations at Major Ophthalmic Industry Conferences – Nasdaq” published on April 29, 2019 as well as Nasdaq.com‘s news article titled: “IRIDEX to Report First Quarter 2019 Financial Results on May 2, 2019 – Nasdaq” with publication date: April 18, 2019.

Investors sentiment increased to 1.05 in 2018 Q4. Its up 0.04, from 1.01 in 2018Q3. It improved, as 45 investors sold MOS shares while 159 reduced holdings. 81 funds opened positions while 134 raised stakes. 286.18 million shares or 5.64% more from 270.90 million shares in 2018Q3 were reported. Cohen And Steers has 0.02% invested in The Mosaic Company (NYSE:MOS). Cornerstone Advisors Incorporated invested in 1,685 shares. Royal London Asset accumulated 0.04% or 144,159 shares. Bancorp Of Hawaii owns 30,714 shares. Bank Of Montreal Can accumulated 0.01% or 217,450 shares. Moreover, Lmr Partners Ltd Liability Partnership has 0.06% invested in The Mosaic Company (NYSE:MOS) for 44,580 shares. State Of New Jersey Common Pension Fund D has invested 0% in The Mosaic Company (NYSE:MOS). Moreover, Headinvest Limited Liability has 0.08% invested in The Mosaic Company (NYSE:MOS). Stone Ridge Asset Mgmt invested in 0.01% or 6,869 shares. Benjamin F Edwards And accumulated 1,227 shares or 0% of the stock. Adage Cap Prtnrs Group Ltd Limited Liability Company has invested 0.71% in The Mosaic Company (NYSE:MOS). Bartlett Lc holds 0% of its portfolio in The Mosaic Company (NYSE:MOS) for 1,000 shares. Moreover, Federated Pa has 0.04% invested in The Mosaic Company (NYSE:MOS) for 486,073 shares. Moreover, Public Employees Retirement Systems Of Ohio has 0.02% invested in The Mosaic Company (NYSE:MOS). Oregon Pub Employees Retirement Fund holds 0.12% of its portfolio in The Mosaic Company (NYSE:MOS) for 4.69M shares.

Among 8 analysts covering Mosaic (NYSE:MOS), 3 have Buy rating, 0 Sell and 5 Hold. Therefore 38% are positive. Mosaic has $42 highest and $30 lowest target. $35.89’s average target is 54.37% above currents $23.25 stock price. Mosaic had 14 analyst reports since December 12, 2018 according to SRatingsIntel. The stock of The Mosaic Company (NYSE:MOS) has “Hold” rating given on Tuesday, April 9 by Stifel Nicolaus. On Tuesday, March 26 the stock rating was initiated by Berenberg with “Hold”. Cowen & Co maintained The Mosaic Company (NYSE:MOS) on Tuesday, March 5 with “Buy” rating. UBS maintained The Mosaic Company (NYSE:MOS) on Monday, April 1 with “Buy” rating. The firm earned “Market Perform” rating on Friday, March 29 by BMO Capital Markets. The firm has “Buy” rating by Susquehanna given on Tuesday, February 26. JP Morgan downgraded the stock to “Neutral” rating in Wednesday, December 12 report. The stock of The Mosaic Company (NYSE:MOS) earned “Buy” rating by UBS on Tuesday, February 26. Citigroup maintained the stock with “Buy” rating in Wednesday, February 27 report. Barclays Capital maintained The Mosaic Company (NYSE:MOS) rating on Wednesday, February 27. Barclays Capital has “Hold” rating and $37 target.

Analysts await The Mosaic Company (NYSE:MOS) to report earnings on August, 5. They expect $0.60 EPS, up 50.00% or $0.20 from last year’s $0.4 per share. MOS’s profit will be $231.48M for 9.69 P/E if the $0.60 EPS becomes a reality. After $0.25 actual EPS reported by The Mosaic Company for the previous quarter, Wall Street now forecasts 140.00% EPS growth.

Kempner Capital Management Inc increased Zimmerbiomethldgsinc (ZMH) stake by 2,938 shares to 13,801 valued at $1.43 million in 2018Q4. It also upped Dowdupont Inc stake by 14,640 shares and now owns 66,843 shares. Applied Materials (NASDAQ:AMAT) was raised too.

IRIDEX Corporation (NASDAQ:IRIX) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

All 30 SOX components are falling, AMD and Micron stocks were the most active decliners

Elsewhere, shares of Micron Technology Inc. MU, -3.67% shed 3.8%, Intel Corp. INTC, -1.22% fell 1.4%, Qualcomm Inc. QCOM, -2.17% lost 2.1% and …

Chip stocks are taking a broad beating Monday, as fears that the sector would be among the most hurt by an escalation in the U.S.-China trade dispute. The NYSE Semiconductor Index SOX, -1.72% slid 2.6% with all 30 components losing ground, while the S&P 500 SPX, -0.45% lost 1.0%. Among the most-active components, Advanced Micro Devices Inc.’s stock AMD, -2.83% dropped 3.9% on volume of about 52 million shares, enough to make it the most actively traded on major U.S. exchanges. Elsewhere, shares of Micron Technology Inc. MU, -2.77% shed 3.8%, Intel Corp. INTC, -0.42% fell 1.4%, Qualcomm Inc. QCOM, -1.16% lost 2.1% and Nvidia Corp. NVDA, -1.73% gave up 2.8%. Microchip Technology Inc.’s stock MCHP, -3.74% slumped 4.3% to pace the decliners. Wedbush analyst Dan Ives said the semiconductor space remains “front and center” in the trade talks, given that the resolution of intellectual protocol issues in China is a major focus of the sector. The selloff comes after President Donald Trump tweeted over the weekend threatening to impose additional tariffs on China-made goods.

Have breaking news sent to your inbox. Subscribe to MarketWatch’s free Bulletin emails. Sign up here.

Fortress Biotech (FBIO) Shares Up 7.5%

Two Sigma Investments LP boosted its holdings in shares of Fortress Biotech by 96.5% during the fourth quarter. Two Sigma Investments LP now …

Fortress Biotech logoFortress Biotech (NASDAQ:FBIO)’s share price shot up 7.5% during trading on Friday . The company traded as high as $1.74 and last traded at $1.72. 651,802 shares were traded during mid-day trading, a decline of 19% from the average session volume of 803,401 shares. The stock had previously closed at $1.60.

A number of research firms have commented on FBIO. Zacks Investment Research downgraded shares of Fortress Biotech from a “buy” rating to a “hold” rating in a report on Tuesday, April 16th. HC Wainwright reissued a “buy” rating and set a $11.00 price target on shares of Fortress Biotech in a report on Wednesday, February 20th. Finally, ValuEngine raised shares of Fortress Biotech from a “hold” rating to a “buy” rating in a report on Saturday, February 2nd.

The company has a current ratio of 2.00, a quick ratio of 1.99 and a debt-to-equity ratio of 3.06.

Fortress Biotech (NASDAQ:FBIO) last announced its quarterly earnings results on Monday, March 18th. The biopharmaceutical company reported ($0.58) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.58). Fortress Biotech had a negative net margin of 30.52% and a negative return on equity of 113.66%. As a group, research analysts expect that Fortress Biotech will post -2.28 earnings per share for the current year.

Several institutional investors and hedge funds have recently made changes to their positions in FBIO. Two Sigma Investments LP boosted its holdings in shares of Fortress Biotech by 96.5% during the fourth quarter. Two Sigma Investments LP now owns 30,954 shares of the biopharmaceutical company’s stock valued at $27,000 after acquiring an additional 15,200 shares during the period. Shikiar Asset Management Inc. boosted its holdings in shares of Fortress Biotech by 158.7% during the fourth quarter. Shikiar Asset Management Inc. now owns 32,600 shares of the biopharmaceutical company’s stock valued at $28,000 after acquiring an additional 20,000 shares during the period. Dowling & Yahnke LLC acquired a new position in shares of Fortress Biotech during the first quarter valued at $36,000. SG Americas Securities LLC acquired a new position in shares of Fortress Biotech during the fourth quarter valued at $38,000. Finally, Rhumbline Advisers boosted its holdings in shares of Fortress Biotech by 45.7% during the fourth quarter. Rhumbline Advisers now owns 45,131 shares of the biopharmaceutical company’s stock valued at $39,000 after acquiring an additional 14,150 shares during the period. 12.39% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Finance Daily and is the sole property of of Finance Daily. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.fidaily.com/2019/05/05/fortress-biotech-fbio-shares-up-7-5.html.

Fortress Biotech Company Profile (NASDAQ:FBIO)

Fortress Biotech, Inc develops and commercializes pharmaceutical and biotechnology products. The company develops CNDO-109, a lysate that treats cancer-related and other conditions; tramadol HCl for managing postoperative pain; CAEL-101 for the treatment of amyloid light chain amyloidosis; and CEVA101 for severe traumatic brain injury in children and adults in the United States.

Further Reading: What is the Bid-Ask Spread?

Receive News & Ratings for Fortress Biotech Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Fortress Biotech and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Aurora Cannabis Inc. (ACB) Analysts See $-0.05 EPS; SK Telecom CO LTD. (SKM) Shorts Raised …

SK Telecom CO LTD. (NYSE:SKM) had an increase of 36.04% in short interest. SKM’s SI was 959,600 shares in May as released by FINRA.

SK Telecom Co., Ltd. (NYSE:SKM) Logo

SK Telecom CO LTD. (NYSE:SKM) had an increase of 36.04% in short interest. SKM’s SI was 959,600 shares in May as released by FINRA. Its up 36.04% from 705,400 shares previously. With 424,100 avg volume, 2 days are for SK Telecom CO LTD. (NYSE:SKM)’s short sellers to cover SKM’s short positions. The SI to SK Telecom CO LTD.’s float is 0.22%. The stock increased 2.60% or $0.62 during the last trading session, reaching $24.43. About 478,716 shares traded or 28.00% up from the average. SK Telecom Co., Ltd. (NYSE:SKM) has risen 5.21% since May 4, 2018 and is uptrending. It has outperformed by 0.84% the S&P500. Some Historical SKM News: 15/03/2018 – S.Korea’s SK Telecom says considering acquiring Carlyle’s ADT Caps; 07/05/2018 – SK TELECOM, MACQUARIE TO BUY ADT CAPS FOR 1.28T WON; 08/05/2018 – REG-SK TELECOM CO LD: DECISION ON ACQUISITION OF SHK; 19/03/2018 – REG-SK Telecom Co Ld: Reply to the request by the Korea Exchange; 10/05/2018 – Moody’s Revises Sk Telecom’s A3 Ratings Outlook To Negative; 07/05/2018 – S.KOREA’S SK TELECOM SAYS TO BUY 702 BLN WON WORTH STAKE IN OWNER OF SECURITY FIRM ADT CAPS; 22/03/2018 – REG-SK Telecom Co Ld: Results of the AGM of shareholders; 04/05/2018 – REG-SK Telecom Co Ld: 2018 1Q Earnings Results; 07/05/2018 – S.Korea’s SK Telecom to buy majority stake in parent of Carlyle-owned ADT Caps; 04/05/2018 – SK Telecom Co Ld (GDR): 2018 1Q Earnings Results

Analysts expect Aurora Cannabis Inc. (TSE:ACB) to report $-0.05 EPS on May, 14.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.05 EPS. After having $-0.05 EPS previously, Aurora Cannabis Inc.’s analysts see 0.00% EPS growth. The stock decreased 0.08% or $0.01 during the last trading session, reaching $11.8. About 3.18 million shares traded. Aurora Cannabis Inc. (TSE:ACB) has 0.00% since May 4, 2018 and is . It has underperformed by 4.37% the S&P500.

More notable recent Aurora Cannabis Inc. (TSE:ACB) news were published by: Midasletter.com which released: “Aurora Cannabis Inc (TSE:ACB NYSE:ACB) Awarded Maximum Lots in German Tender Process – Midas Letter” on April 12, 2019, also Midasletter.com with their article: “Investors Buy Aurora Cannabis Inc (TSE:ACB) Gap Down Post-Earnings – Midas Letter” published on February 12, 2019, Midasletter.com published: “Aurora Cannabis Inc (TSE:ACB | NYSE:ACB) Q2 Revenues Surge 83 Percent – Midas Letter” on February 22, 2019. More interesting news about Aurora Cannabis Inc. (TSE:ACB) were released by: Midasletter.com and their article: “Market Reacts Forcefully To Aurora Cannabis Inc (TSE:ACB) $250M Note Offering – Midas Letter” published on January 17, 2019 as well as Midasletter.com‘s news article titled: “Aurora Cannabis Inc (TSE:ACB) Secures An Elite Strategic Advisor To Its Ranks – Midas Letter” with publication date: March 13, 2019.

Among 3 analysts covering Aurora Cannabis (TSE:ACB), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aurora Cannabis had 6 analyst reports since February 21, 2019 according to SRatingsIntel. The firm has “Buy” rating by Cowen & Co given on Tuesday, March 5. Jefferies initiated it with “Buy” rating and $12 target in Monday, February 25 report. The stock of Aurora Cannabis Inc. (TSE:ACB) has “Buy” rating given on Wednesday, March 13 by GMP Securities. On Wednesday, March 13 the stock rating was maintained by Cowen & Co with “Buy”.

Aurora Cannabis Inc., together with its subsidiaries, produces and distributes medical marijuana products in Canada. The company has market cap of $11.98 billion. The company’s products consist of dried cannabis and cannabis oil. It currently has negative earnings. It also operates as a pharmaceutical wholesaler and narcotics dealer of medical marijuana in Germany and the European Union; and produces and sells proprietary systems for the indoor cultivation of cannabis, organic microgreens, vegetables, and herbs.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Analysts See $-0.34 EPS for Anaplan, Inc. (PLAN); Harding Loevner LP Decreased Cnooc LTD …

Harding Loevner Lp decreased Cnooc Ltd (CEO) stake by 4.89% reported in 2018Q4 SEC filing. Harding Loevner Lp sold 78,106 shares as Cnooc …

CNOOC Limited (NYSE:CEO) Logo

Harding Loevner Lp decreased Cnooc Ltd (CEO) stake by 4.89% reported in 2018Q4 SEC filing. Harding Loevner Lp sold 78,106 shares as Cnooc Ltd (CEO)’s stock rose 7.25%. The Harding Loevner Lp holds 1.52M shares with $231.36M value, down from 1.60 million last quarter. Cnooc Ltd now has $77.62B valuation. The stock increased 0.51% or $0.89 during the last trading session, reaching $176.04. About 37,192 shares traded. CNOOC Limited (NYSE:CEO) has risen 23.28% since May 3, 2018 and is uptrending. It has outperformed by 18.91% the S&P500. Some Historical CEO News: 27/04/2018 – CNOOC Limited Announces Changes in Directors; 29/03/2018 – CNOOC Limited: Reserve and Profit Significantly Increased, Net Profit Greatly Improved; 20/04/2018 – CNOOC LTD 0883.HK – PROCEEDS OF PROPOSED NOTES ISSUE WILL BE USED IN PART TO REPAY ALL OR PART OF CERTAIN OUTSTANDING BORROWINGS OF A UNIT; 20/04/2018 – CNOOC LTD 0883.HK – UNIT PROPOSES TO OFFER NOTES TO PROFESSIONAL INVESTORS IN HONG KONG AND ELSEWHERE OUTSIDE UNITED STATES, AND IN UNITED STATES; 29/03/2018 – CNOOC FY NET INCOME 24.68B YUAN, EST. 30.99B YUAN; 29/03/2018 – Cnooc Boosts Dividend, Reserves While Writedowns Punish Profits; 29/03/2018 – Cnooc: 2017 Oil-and-Gas Sales CNY151.89 Billion Vs. CNY121.33 Billion Year Earlier; 20/04/2018 – CNOOC XIE: SEE CHALLENGES IN ACHIEVING 70-80B YUAN CAPEX TARGET; 20/03/2018 – CNOOC Limited Announces Weizhou 6-13 Oilfield Commences Production; 18/05/2018 – CNOOC: Husky Shall Act as Operator During Exploration Period, Conduct Exploration Activities

Analysts expect Anaplan, Inc. (NYSE:PLAN) to report $-0.34 EPS on May, 27.After having $-0.26 EPS previously, Anaplan, Inc.’s analysts see 30.77% EPS growth. The stock increased 1.44% or $0.56 during the last trading session, reaching $39.42. About 283,819 shares traded. Anaplan, Inc. (NYSE:PLAN) has 0.00% since May 3, 2018 and is . It has underperformed by 4.37% the S&P500.

Harding Loevner Lp increased Amazon Com Inc (NASDAQ:AMZN) stake by 8,779 shares to 134,981 valued at $202.74M in 2018Q4. It also upped Grifols S A (NASDAQ:GRFS) stake by 520,797 shares and now owns 17.24 million shares. Bancolombia S A (NYSE:CIB) was raised too.

More notable recent CNOOC Limited (NYSE:CEO) news were published by: Finance.Yahoo.com which released: “Is Genuine Parts Company’s (NYSE:GPC) CEO Pay Fair? – Yahoo Finance” on May 03, 2019, also Finance.Yahoo.com with their article: “Is Stepan Company (NYSE:SCL) Excessively Paying Its CEO? – Yahoo Finance” published on May 03, 2019, Finance.Yahoo.com published: “Is Generac Holdings Inc.’s (NYSE:GNRC) CEO Salary Justified? – Yahoo Finance” on May 03, 2019. More interesting news about CNOOC Limited (NYSE:CEO) were released by: Finance.Yahoo.com and their article: “How Much Did Johnson & Johnson’s (NYSE:JNJ) CEO Pocket Last Year? – Yahoo Finance” published on May 01, 2019 as well as Benzinga.com‘s news article titled: “Shareholders Sue Madison Square Garden (NYSE:MSG), Say CEO James Dolan Is Overpaid – Benzinga” with publication date: May 02, 2019.

More notable recent Anaplan, Inc. (NYSE:PLAN) news were published by: 247Wallst.com which released: “Jefferies Sees 4 Huge Winners in Potential $2 Trillion Infrastructure Plan – 24/7 Wall St.” on May 03, 2019, also Bloomberg.com with their article: “Slack Reveals Losses Amid Rapid Growth in Plan to Go Public – Bloomberg” published on April 26, 2019, Seekingalpha.com published: “Tesla and Markel start to work out insurance plan – Seeking Alpha” on May 01, 2019. More interesting news about Anaplan, Inc. (NYSE:PLAN) were released by: Ft.com and their article: “Nasdaq chief doubles down on data as NYSE fight intensifies – Financial Times” published on May 03, 2019 as well as Fool.com‘s news article titled: “20 High-Growth Stocks for the Next 20 Years – Motley Fool” with publication date: April 29, 2019.

Anaplan, Inc. provides a cloud-based connected planning platform Its platform unites traditionally distinct or disconnected database structures, including relational, columnar, and online analytical processing with in-memory data storage and calculation that is used in various lines of business, such as finance, sales, supply chain, marketing, human resources, and operations. The company has market cap of $4.98 billion. The firm delivers its application over the Internet as a subscription service using a software-as-a-service model. It currently has negative earnings. It operates in the United States, the United Kingdom, France, Belgium, Sweden, the Netherlands, Russia, Austria, Switzerland, Germany, Australia, Singapore, Japan, and India.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts